Disc Medicine Inc. officer William Savage filed a Form 144 notice of proposed sale of 16,035 shares of common stock, with an approximate sale date of November 10, 2026, through Morgan Stanley Smith Barney LLC Executive Financial Services.

Key Highlights

  • Seller and role: William Savage, identified as an officer of Disc Medicine Inc.
  • Shares proposed for sale: 16,035 shares of common stock, with an aggregate market value of $1,303,004.10 according to the filing.
  • Shares outstanding: The filing reports 45,540,842 shares of common stock outstanding.
  • Source of shares: The shares were acquired on June 27, 2025, via previously exercised options from the issuer, with payment made in cash on the same date.
  • 10b5-1 plan: The filing indicates a Rule 10b5-1 plan adoption date of April 10, 2026.
  • No prior sales reported: The filing states "Nothing to Report" for securities sold during the past three months.
  • Exchange listed: NASDAQ, with the filing identifying the issuer as DISC MEDICINE INC (NASDAQ:IRON per the filing's exchange field, SEC File Number 001-39438).

Disc Medicine Officer Files Rule 144 Notice for Proposed Common Stock Sale

According to the Form 144 filed on November 10, 2026, William Savage, an officer of Disc Medicine Inc., provided notice of a proposed sale of 16,035 shares of the company's common stock. The filing lists the aggregate market value of those shares at $1,303,004.10 and identifies the approximate date of sale as November 10, 2026. The designated broker for the transaction is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

The filing discloses that the 16,035 shares were acquired on June 27, 2025, through previously exercised options granted by the issuer, with payment made in cash on that same date. Disc Medicine Inc. is listed on NASDAQ and is headquartered at 321 Arsenal Street, Suite 101, Watertown, Massachusetts 02472, according to the filing's issuer information section.

The notice indicates that Savage is relying on Rule 10b5-1, with a plan adoption date of April 10, 2026. The filing's representation section states that the person for whose account the securities are to be sold does not know any material adverse information regarding the current and prospective operations of the issuer that has not been publicly disclosed. No securities of Disc Medicine were reported as sold by Savage during the three months preceding the notice.

What Was Disclosed

Disc Medicine Inc. officer William Savage filed a Form 144 notice proposing to sell 16,035 shares of common stock, acquired via previously exercised options in June 2025, with an aggregate market value of $1,303,004.10 and an approximate sale date of November 10, 2026.